Healthcare: February 2017

Thursday, February 2, 2017

Bird flu virus found in Belgium, steps taken to contain it - statement

BRUSSELS, Feb 2 (Reuters) - Belgian authorities found the

H5N8 bird flu virus at a farm north of Brussels on Feb.1 and

imposed measures to contain the spread of the highly contagious

virus, the Belgian agriculture ministry said on its website on

Thursday.

Read more

U.S. House panel to take up bill to spur generic drug development

WASHINGTON, Feb 2 (Reuters) - A U.S. House of

Representatives subcommittee will take up bipartisan legislation

next week to spur generic drug development, the committee's

chairman Representative Greg Walden said on Thursday.

Read more

BRIEF-Medivir says EGM backs redemption programme

* Medivir says egm resolved on a voluntary redemption

programme comprising reduction of share capital for repayment to

shareholders and bonus issue without issuance of new shares

Read more

Opioid addiction implant maker Braeburn Pharma pulls IPO

Feb 2 (Reuters) - Braeburn Pharmaceuticals Inc, the maker of

the first long-acting implant to treat opioid addiction in the

United States, said on Thursday that it had decided not to

proceed with its initial public offering, citing current market

environment.

Read more

BRIEF-QT Vascular signs deal with Medtronic for Chocolate PTA catheter

* Qt vascular signs agreement with medtronic for

distribution of chocolate pta catheter

Read more

BRIEF-Japan high court rules in Lilly's favor on Alimta patents

* Japan ip high court rules in lilly's favor on alimta

vitamin regimen patents

Read more

BRIEF-Hologic launches next-generation Novasure advanced global endometrial ablation system for the treatment of abnormal uterine bleeding

* Hologic launches next-generation Novasure advanced global

endometrial ablation system for the treatment of abnormal

uterine bleeding

Source text for Eikon:

Further company coverage:

Read more

BRIEF-AMAG Pharmaceuticals Inc says announced results from its definitive pharmacokinetic study

* AMAG Pharmaceuticals Inc says announced results from its

definitive pharmacokinetic (PK) study

Read more

BRIEF-Nabriva Therapeutics anticipate topline data from phase 3 trials in second half of 2017

* Nabriva therapeutics confirms no sample size adjustment

required for leap 1 phase 3 trial of lefamulin in community

acquired bacterial pneumonia

Read more

BRIEF-Trillium Therapeutics Inc intends to provide an update on ongoing TTI-621 trials

* Trillium Therapeutics Inc - intends to provide an update

on ongoing TTI-621 trials by year-end.

Read more

BRIEF-Becton Dickinson Q1 earnings per share $2.58

* Becton dickinson and co says raising expected full fiscal

year 2017 adjusted diluted earnings per share to $9.70 to $9.80

Read more

BRIEF-Exact Sciences says Cologuard included in medicare advantage advance notice, draft call letter

* Exact Sciences Corp says that Cologuard is included in

medicare advantage advance notice and draft call letter

Source text for Eikon:

Further company coverage:

Read more

BRIEF-Scandinavian ChemoTech signs second LOI in Philippines

Feb 2 (Reuters) - Scandinavian ChemoTech AB :

* Signs second Letter of Intent (LOI) in Philippines

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

BRIEF-AstraZeneca CEO says MYSTIC cancer drug trial "not binary"

Feb 2 (Reuters) - Astrazeneca CEO Pascal Soriot told

reporters after Q4 results:

Read more

BRIEF-Dr. Lal Pathlabs declares interim dividend of 1.30 rupees per share

* Dr. Lal Pathlabs Ltd says have declared an interim

dividend of Rs. 1.30 per equity share

Source text - (Dr. Lal PathLabs Ltd has informed BSE that the

Board of Directors of the Company

at its meeting held on February 02, 2017, inter alia, have

declared an interim dividend of Rs. 1.30 per equity share (@ 13

% on a face value of Rs. 10/- per share) for the Financial Year

2016-17.)

Further company coverage:

Read more

BRIEF-Dr. Lal Pathlabs Dec-qtr profit falls

* Dec quarter net profit 308.7 million rupees versus 608.2

million rupees year ago

Read more

UPDATE 2-AstraZeneca faces falling profit while awaits key drug data

* All eyes on mid-year results from lung cancer trial

(Adds shares, further details on cancer drug competition)

Read more

European shares edge lower on disappointing company updates

LONDON, Feb 2 (Reuters) - European shares fell on Thursday

after disappointing company updates, with Denmark's Novo Nordisk

leading the market down and Finnish retailer Kesko

weakening on lower-than-expected sales.

Read more

Wednesday, February 1, 2017

BRIEF-Pharnext announces findings evaluating Charcot-Marie-Tooth Neuropathy Score

* Pharnext announces findings evaluating Charcot-Marie-Tooth

Neuropathy Score

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more

BRIEF-Karolinska Development: OssDsign signs distribution agreement in USA

* Says its portfolio company OssDsign announces agreement for distribution of OSSDSIGN

Cranial in the USA with Matador Medical Inc.

Source text for Eikon:

Further company coverage:

(Gdynia Newsroom)

Read more

BRIEF-Biotec Pharmacon Q4 EBITDA loss widens to NOK 8.1 mln

* Q4 revenue 18.2 million Norwegian crowns ($2.2

million)versus 13.1 million crowns year ago

Read more

Swiss stocks - Factors to watch on Feb 2

ZURICH, Feb 2 (Reuters) - The following are some of the main

factors expected to affect Swiss stocks on Thursday:

Read more

BRIEF-Parexel International reports Q2 GAAP earnings $0.41/shr

* Parexel international reports second quarter fiscal year

2017 results

Read more

BRIEF-Creso Pharma says Australian loi signed for import & sale of cannabis products

* Australian loi signed for import & sale of cannabis

products

Read more

BRIEF-Interojo issues FY 2017 revenue outlook

* Sees sales revenue of 90.6 billion won and operating

profit of 27.2 billion won for FY 2017

Read more

BRIEF-I-Sens issues FY 2017 revenue outlook

* Sees sales revenue of 165 billion won and operating profit

of 30.3 billion won for FY 2017

Read more

MIDEAST STOCKS - Factors to watch - Feb 2

DUBAI, Feb 2 (Reuters) - Here are some factors that may

affect Middle East stock markets on Thursday. Reuters has not

verified the press reports and does not vouch for their

accuracy.

Read more

BRIEF-TaiwanJ Pharmaceuticals starts Phase 2 clinical study on Autoimmune Hepatitis

* Says it began JKB-122 Phase 2 clinical study on Autoimmune

Hepatitis, an orphan disease, in late January and the study is

expected to last for 16 weeks

Read more

UPDATE 2-Medical group urges protection for doctors, patients after U.S. travel ban

SAN FRANCISCO, Feb 1 (Reuters) - The largest U.S. physician

group urged President Donald Trump's administration on Wednesday

to protect international doctors and seriously ill patients from

an executive order that suspends travel from seven

Muslim-majority countries.

Read more

UPDATE 1-Ex-Tenet Healthcare executive accused by U.S. of fraud

Feb 1 (Reuters) - A former senior executive of Tenet

Healthcare Corp has been indicted on charges that he

participated in a scheme to pay bribes for patient referrals,

enabling the U.S. hospital chain to fraudulently bill state

Medicaid programs for $400 million.

Read more

BRIEF-Parexel International agrees to acquire Medical Affairs Company

* Parexel announces definitive agreement to acquire the

Medical Affairs Company

Read more

Malaria superbugs threaten global malaria control, scientists say

LONDON, Feb 2 (Reuters) - Multidrug-resistant malaria

superbugs have taken hold in parts of Thailand, Laos and

Cambodia, threatening to undermine progress against the disease,

scientists said.

Read more

Ex-Tenet Healthcare executive charged in fraud scheme -U.S. Justice Dept

WASHINGTON, Feb 1 (Reuters) - A former senior executive of

U.S. hospital chain Tenet Healthcare Corp has been

charged for his alleged role in a $400 million scheme to defraud

the U.S. government, the Georgia and South Carolina Medicaid

programs, and Tenet patients, the U.S. Justice Department said

on Wednesday.

Read more

BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee

* J&J - upon termination of transaction agreement, under

some circumstances, Actelion may be obligated to pay co a fee -

sec filing

Source text - http://bit.ly/2jWFeAh

Further company coverage:

Read more

BRIEF-Capnia files for sale of up to 10 mln shares of common stock

* Files for sale of up to 10.0 million shares of co's common

stock by Aspire Capital Fund, LLC - SEC filing

Source text: [http://bit.ly/2kXj1Sw]

Further company coverage:

Read more

BRIEF-Conmed Q4 adjusted earnings per share $0.54

* Conmed Corporation announces fourth quarter and fiscal

year 2016 financial results

Read more

BRIEF-Hologic Q1 non-gaap EPS $0.52

* Hologic announces financial results for first quarter of

fiscal 2017

Read more

BRIEF-Bioanalytical Systems says co entered into fifth forbearance agreement and sixth amendment to credit agreement

* Bioanalytical Systems - effective Jan 31, co entered into

a fifth forbearance agreement and sixth amendment to credit

agreement - SEC filing

Read more

UPDATE 1-Medical helicopter company Air Methods exploring sale - WSJ

Feb 1 (Reuters) - U.S. medical helicopter company Air

Methods Corp is exploring a sale, the Wall Street

Journal reported, citing people familiar with the matter.

Read more

Zika ebbing in Latin America but vigilance needed -WHO

* Latin America reporting fewer Zika cases, no second wave

seen

Read more

BRIEF-Medical helicopter company Air Methods exploring sale- WSJ, citing sources

* Medical helicopter company air methods exploring a sale-

WSJ, citing sources

Source text : http://on.wsj.com/2jVSaGE

Read more

UPDATE 1-Senate delays vote on Trump EPA pick after Democrats boycott

WASHINGTON, Feb 1 (Reuters) - Republican U.S. senators on

Wednesday delayed a committee vote on President Donald Trump's

pick to head the Environmental Protection Agency, after the

panel's Democrats boycotted the meeting, saying that nominee

Scott Pruitt doubts the science of climate change.

Read more

BRIEF-Bristol-Myers squibb announces European Patent Office decision on Sprycel

* Bristol-Myers Squibb announces European Patent Office

decision on Sprycel

Read more

BRIEF-Roche confirms 2017 guidance irrespective of aphinity trial outcome

* Ceo says confirms 2017 guidance irrespective of outcome of

aphinity trial

Source text for Eikon:

Further company coverage:

(Reporting by John Miller)

Read more

BRIEF-SHL Telemedicine accepts resignation of CEO Yuval Shaked

* Announced today that board of directors has accepted

resignation of Yuval Shaked, SHL'S CEO

Read more

BRIEF-Jacobson Pharma says Pun Yue Wai appointed executive director

* Lo Chun Bun has resigned as an executive director

Source text for Eikon:

Further company coverage:

Read more

'Integrity Idol' winner vows to use prize to train health workers in post-Ebola Liberia

MONROVIA, Feb 1 (Thomson Reuters Foundation) - The winner of

Integrity Idol, a Liberian reality TV show, plans to use his

prize money to train health workers as the country is still

reeling from the world's worst Ebola outbreak.

Read more

BRIEF-Critical outcome technologies announces departure of chief scientific officer

* Critical outcome technologies announces departure of chief

scientific officer

Source text for Eikon:

Further company coverage:

Read more

BRIEF-Tetra Bio-Pharma receives notice of authorization from Health Canada

* Tetra Bio-Pharma Inc receives notice of authorization from

Health Canada for the conduct of its clinical trial with its

PPTGR topical product

Source text for Eikon:

Further company coverage:

Read more

Anthem CEO says weighing 2018 participation in Obamacare plans

NEW YORK, Feb 1 (Reuters) - Anthem Inc. Chief

Executive Officer Joseph Swedish on Wednesday laid out a list of

short-term changes designed to stabilize the market as the new

Republican administration and Congress seek to change Obamacare.

Read more